两融数据显示，该股最新融资余额为1.14亿元，近5日减少1753.49万元，降幅为13.34%。（数据宝） 8月13日三友医疗大宗交易一览 | 成交量 （万 | 成交金额 | 成交价 | 相对当日收盘 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | | | （万元） | 格 | 折溢价（%） | | | | 股） | | （元） | | | | | 43.56 | 740.52 | 17.00 | -21.00 | 华泰证券股份有限公司上海徐 | 华林证券股份有限 | | | | | | 汇区龙启路证券营业部 | 公司上海分公司 | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 三友医疗8月13日大宗交易平台出现一笔成交，成交量43.56万股，成交金额740.52万元，大宗交易成交 价为17.00元，相对今日收盘价折价21.00%。该笔交易的买方营业部为华泰证券股份有限公司上海徐汇 区龙启路证券营业部，卖方营业部为华林证券股份有限公司上海分公司。 进一步统计，近3个月内该股累计发生5笔大宗交易，合计成交金额为6942.12万元。 ...

Summary of Key Points Core Viewpoint - The announcement details a share reduction plan by Xu Nong, a significant shareholder of Shanghai Sanyou Medical Devices Co., Ltd., due to personal financial needs, involving a maximum reduction of 6,669,249 shares, representing up to 2.00% of the company's total share capital [1][4]. Group 1: Basic Information - As of the announcement date, Xu Nong directly holds 30,341,922 shares, while his action group, including David Fan, holds a total of 94,856,415 shares, accounting for 28.45% of the company [1][3]. - The action group includes the asset management plan "Chaos Tiancheng 18," which holds 8,881,404 shares, representing 2.66% of the total shares [2][4]. Group 2: Reduction Plan Details - Xu Nong plans to reduce his holdings through block trading, with the reduction period set from September 8, 2025, to December 8, 2025 [1][4]. - The maximum number of shares to be reduced is 6,669,249, and the plan is subject to a commitment that no more than 2.00% of the total shares will be sold within any consecutive 90-day period [1][4]. Group 3: Compliance and Commitments - Xu Nong and his action group have signed an agreement to form a concerted action relationship, ensuring compliance with relevant regulations regarding shareholding and reduction [3][4]. - The announcement confirms that the reduction plan aligns with previous commitments made by the shareholders regarding shareholding and trading [8][9].

证券代码：688085 证券简称：三友医疗 公告编号：2025-055 上海三友医疗器械股份有限公司 关于实际控制人的一致行动人的减持计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 基本情况 截至本公告披露日，上海三友医疗器械股份有限公司（以下简称"公司"） 实际控制人之一、董事兼总裁徐农先生的一致行动人混沌天成资管－徐农－混沌 天成精选策略 18 号单一资产管理计划（以下简称"混沌天成 18 号"）直接持有 公司股份 8,881,404 股，占公司总股本 2.66%。徐农先生直接持有公司股份 39,297,975 股，其一致行动人 Michael Mingyan Liu（刘明岩）先生直接持有公 司股份 30,341,922 股、David Fan（范湘龙）先生直接持有公司股份 16,335,114 股。上述一致行动人合计持有公司 94,856,415 股，占比 28.45%。 减持计划的主要内容 近日，公司收到徐农先生《关于股份减持的告知函》，徐农先生因个人资金 需求，拟通过大宗交易 ...

Core Viewpoint - Sanyou Medical (688085.SH) announced that its president Xu Nong plans to reduce his shareholding due to personal financial needs, indicating potential changes in insider ownership and market sentiment [1] Summary by Sections Shareholding Reduction - Xu Nong intends to reduce his holdings by up to 6.6692 million shares, which represents no more than 2.00% of the company's total share capital [1] - The reduction will be executed through block trading and is scheduled to take place within three months from September 8, 2025, to December 7, 2025 [1] - During any consecutive 90-day period, the total number of shares sold will not exceed 2% of the company's total shares [1] Trading Restrictions - If there are restrictions on trading windows during the implementation period, the share reduction will be halted [1]

Core Viewpoint - The company announced a plan for a significant share reduction by a major shareholder due to personal financial needs, which may impact investor sentiment and stock performance [1] Group 1: Shareholder Actions - The actual controller and president of the company, Xu Nong, through a related party, plans to reduce holdings by up to 6.6692 million shares, representing no more than 2% of the total share capital [1] - The reduction is scheduled to occur between September 8, 2025, and December 7, 2025, via block trading [1] - The implementation of this reduction plan carries uncertainty [1]

| 2025-08-13 | 三友医疗 | 688085 | 17 740.52 43.56 | 华泰证券股份有限 公司上海徐汇区龙 who redu how like shops. II allery | 华林证券股份有限 | | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | 卖出营业部 公司上海分公司 | 8月13日，三友医疗大宗交易成交43.56万股，成交额740.52万元，占当日总成交额的6.13%，成交价17元，较市场收盘价21.52元折价21%。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688085 证券简称：三友医疗 公告编号：2025-054 根据上述决议，公司在规定期限内实际使用人民币7,475.00万元闲置募集资金暂时补充流动资金，并对 资金进行了合理的安排与使用，未影响募集资金投资计划的正常进行，资金运用情况良好。 2025年8月4日，公司将上述暂时补充流动资金的人民币7,475.00万元全部归还至募集资金专用账户。上 述募集资金的归还情况已通知公司的保荐机构及保荐代表人。 上海三友医疗器械股份有限公司 关于归还暂时补充流动资金的闲置募集资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 上海三友医疗器械股份有限公司（以下简称"三友医疗"或"公司"）于2024年8月27日召开第三届董事会 第十四次会议、第三届监事会第十次会议，审议通过了《关于使用部分闲置募集资金暂时补充流动资金 的议案》，同意公司使用不超过8,000.00万元（含本数）闲置募集资金暂时补充流动资金，用于与公司 主营业务相关的生产经营使用，使用期限自公司董事会审议 ...

证券日报网讯 8月4日晚间，三友医疗发布公告称，公司于2024年8月27日召开第三届董事会第十四次会 议、第三届监事会第十次会议，审议通过了《关于使用部分闲置募集资金暂时补充流动资金的议案》， 同意公司使用不超过8，000.00万元（含本数）闲置募集资金暂时补充流动资金，用于与公司主营业务 相关的生产经营使用，使用期限自公司董事会审议通过之日起不超过12个月。2025年8月4日，公司将上 述暂时补充流动资金的人民币7，475.00万元全部归还至募集资金专用账户。 （编辑 任世碧） ...

证券代码：688085 证券简称：三友医疗 公告编号：2025-054 上海三友医疗器械股份有限公司 2025 年 8 月 4 日，公司将上述暂时补充流动资金的人民币 7,475.00 万元全 部归还至募集资金专用账户。上述募集资金的归还情况已通知公司的保荐机构及 保荐代表人。 特此公告。 上海三友医疗器械股份有限公司董事会 2025 年 8 月 5 日 关于归还暂时补充流动资金的闲置募集资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海三友医疗器械股份有限公司（以下简称"三友医疗"或"公司"）于 2024 年 8 月 27 日召开第三届董事会第十四次会议、第三届监事会第十次会议，审议 通过了《关于使用部分闲置募集资金暂时补充流动资金的议案》，同意公司使用 不超过 8,000.00 万元（含本数）闲置募集资金暂时补充流动资金，用于与公司 主营业务相关的生产经营使用，使用期限自公司董事会审议通过之日起不超过 12 个月。具体内容请详见公司于 2024 年 8 月 28 日在上海证券交易所网站 （www.sse. ...

Core Viewpoint - The announcement details the share reduction plan executed by David Fan, a director and senior executive of Shanghai Sanyou Medical Equipment Co., Ltd, including the number of shares sold and the impact on ownership percentages [1][4][5]. Summary by Sections Basic Information - David Fan held 17,379,262 shares before the reduction, representing 6.25% of the company's total shares as of the disclosure date [1]. - His concerted actions with Xu Nong and others resulted in a combined holding of 82,813,680 shares, accounting for 29.80% of the total shares [1]. Implementation Results of the Reduction Plan - The reduction plan was disclosed on May 21, 2025, with a maximum of 4,000,000 shares to be sold, equating to 1.44% of the total shares [2]. - The reduction period was set from June 16, 2025, to September 8, 2025, with a limit of 2% of total shares sold within any 90-day period [2]. Share Reduction Details - Between June 16 and June 19, 2025, David Fan sold 2,600,000 shares, followed by an additional 1,400,000 shares sold from June 20 to July 25, 2025, completing the reduction plan [4][5]. - Following the share reduction and a capital increase due to a rights issue, David Fan's ownership percentage decreased from 5.32% to 4.90% [5]. Changes in Shareholding Structure - The total share capital increased from 277,885,415 shares to 333,462,498 shares due to a capital reserve conversion, affecting the shareholding percentages of all shareholders [3][7]. - The combined shareholding of David Fan and his concerted parties decreased from 28.87% to 28.45%, without crossing the 1% or 5% thresholds for reporting [5].